Folic acid and b12 should be co administered in macrocytic anaemia.give reason mbbs phase 1
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Loading Image
Reading File
Loading Image
I now have everything needed for a thorough, exam-oriented answer. Here is the full explanation:
Why Folic Acid and B12 Should Be Co-administered in Macrocytic Anaemia
This is one of the most tested pharmacology/biochemistry concepts in MBBS Phase 1.
1. Background: Two Causes of the Same Anaemia
Both Vitamin B12 (cobalamin) deficiency and Folic acid (folate) deficiency independently produce megaloblastic (macrocytic) anaemia - large, immature red cell precursors in the bone marrow due to impaired DNA synthesis.
In clinical practice (especially in India), a patient presenting with macrocytic anaemia may have:
- Pure folate deficiency
- Pure B12 deficiency
- Combined deficiency (very common)
Without proper lab workup (serum B12, folate levels, methylmalonic acid), distinguishing them is not always possible.
2. The Core Biochemical Link: The "Folate Trap"
This is the key mechanism you must know for your exam.
Fig. 14.18 from Robbins & Cotran Pathologic Basis of Disease - relationship of N5-methyl FH2, methionine synthase, and thymidylate synthetase.
Step-by-step:
- Dietary folate circulates in plasma predominantly as N5-methyl THF (N5-methyl tetrahydrofolate / N5-methyl FH4).
- To be used for DNA synthesis, N5-methyl FH4 must be demethylated to FH4 (tetrahydrofolate) by the enzyme methionine synthase.
- Methionine synthase requires Vitamin B12 (methylcobalamin) as a cofactor. In this reaction:
- N5-methyl FH4 → FH4 (active folate, released)
- Homocysteine → Methionine
- FH4 is then converted to N5,10-methylene FH4, the coenzyme required by thymidylate synthetase to convert dUMP → dTMP, a building block for DNA.
In B12 deficiency:
- Methionine synthase is non-functional (no B12 cofactor)
- Folate gets irreversibly "trapped" as N5-methyl FH4
- Even if folate levels in blood are normal or high, the cell cannot use it
- DNA synthesis fails → megaloblastic changes in RBC precursors
This is called the "Methyl Folate Trap" or "Folate Trap Hypothesis."
"In cobalamin (Cbl) deficiency, folate is sequestered as N5-methyl FH2. This ultimately deprives thymidylate synthetase of its folate coenzyme (N5,10-methylene FH2), thereby impairing DNA synthesis." -- Robbins & Cotran Pathologic Basis of Disease
3. The Critical Danger: Why You MUST Co-administer B12
Here is the main clinical and pharmacological reason:
If you give only folic acid to a patient who actually has B12 deficiency:
| Effect | Explanation |
|---|---|
| Anaemia corrects | High-dose folate can bypass the trap partially and correct the haematological picture |
| Neurological damage continues and worsens | B12 deficiency causes subacute combined degeneration (SCD) of the spinal cord - demyelination of dorsal and lateral columns - which is NOT corrected by folate |
| Masking effect | The corrected blood count gives a false sense of security, while irreversible neurological damage silently progresses |
"Large doses of folic acid given to an individual with an undiagnosed vitamin B12 deficiency could correct megaloblastic anemia, but leave the individual at risk of developing irreversible neurologic damage." -- Tintinalli's Emergency Medicine
"Coexisting vitamin B12 deficiency must be excluded because, in such cases, folate therapy without cobalamin replacement may exacerbate neurological manifestations." -- Bradley and Daroff's Neurology in Clinical Practice
4. Why Neurological Damage Occurs in B12 Deficiency (but NOT in Folate Deficiency Alone)
B12 has a second metabolic function completely independent of folate:
- Adenosylcobalamin is a cofactor for methylmalonyl-CoA mutase
- This enzyme converts methylmalonyl-CoA → succinyl-CoA (part of the TCA cycle)
- In B12 deficiency, methylmalonyl-CoA and methylmalonate accumulate
- This likely leads to abnormal fatty acid synthesis, incorporation of abnormal fatty acids into neuronal myelin, and eventual myelin breakdown
- Result: Subacute Combined Degeneration (SCD) of the spinal cord
- Demyelination of posterior columns (loss of vibration sense, proprioception, Romberg positive)
- Demyelination of lateral corticospinal tracts (UMN signs - spasticity, hyperreflexia)
- Peripheral neuropathy (glove-and-stocking pattern)
Folate supplementation does NOT correct this pathway - only B12 does.
5. Exam Summary: The Two Reasons to Co-administer
| Reason | Mechanism |
|---|---|
| 1. Anaemia may have mixed cause | Both deficiencies produce identical macrocytic anaemia; treating only one leaves the other unaddressed |
| 2. Prevent masking of B12 deficiency | Folate alone corrects the blood picture but allows irreversible neurological damage (SCD) from undiagnosed/untreated B12 deficiency to progress |
6. Two Metabolic Reactions of Vitamin B12 (Memory Peg)
| Reaction | Coenzyme form | Clinical significance |
|---|---|---|
| Homocysteine → Methionine (via methionine synthase) | Methylcobalamin | Folate trap; megaloblastic anaemia |
| Methylmalonyl-CoA → Succinyl-CoA (via methylmalonyl-CoA mutase) | Adenosylcobalamin | Neurological damage (SCD); methylmalonic aciduria |
"Vitamin B12 is utilized in only two reactions in the body." -- Lippincott's Illustrated Reviews: Biochemistry, 8th ed.
Quick Recall for Viva/Exams
- Folate alone can correct the anaemia but NOT the neurology - this is the danger.
- Methylmalonate levels are elevated only in B12 deficiency (not folate) - helps distinguish them.
- Homocysteine is elevated in both.
- The phenomenon is called the "methyl folate trap" or "folate trap."
- The neurological syndrome is subacute combined degeneration (SCD) of the spinal cord.
- Always rule out B12 deficiency before prescribing folic acid alone.
Sources: Robbins & Cotran Pathologic Basis of Disease (14th ed.), p. 610; Tintinalli's Emergency Medicine; Bradley & Daroff's Neurology in Clinical Practice; Lippincott's Illustrated Reviews: Biochemistry, 8th ed.
This is a shared conversation. Sign in to Orris to start your own chat.